Circadian health

Circadian rhythm and seasonal affective disorder

When the days go short, some people do not just feel a little down; they fall into a clinical winter depression. The leading explanation is that the late-rising winter sun knocks the body clock out of step with the sleep schedule, and that the most reliable fix is enough bright light at the right hour of the morning. The catch is the word enough: it is a measurable dose, and the room that feels plenty bright in December is very often nowhere near it.

The connection

Seasonal affective disorder (SAD) is a recurrent major depression that lands in fall and winter and lifts in spring. The trigger is the seasonal collapse of light: shorter days, weaker and later sunrises, far less time outdoors.

Light is also the main signal that sets the human circadian clock, working through melanopsin-containing retinal cells (ipRGCs) that report ambient brightness to the master clock. So the very change that defines winter is also the one best able to throw the circadian system out of line, which is why SAD is studied as a timing disorder and treated chiefly with timed bright light.

The science

The dominant circadian model is the phase-shift hypothesis, worked out by Alfred Lewy and colleagues. In winter, weaker and later morning light lets the clock drift late (a phase delay), so internal rhythms fall out of step with the sleep schedule. Most SAD patients run phase-delayed in winter, a smaller group runs phase-advanced, and mood is best when they are realigned (Lewy et al., 2006; 2007). Morning bright light advances the clock, the direction that corrects the usual winter delay.

A second route is neurochemical. In a study sampling blood from the internal jugular, brain serotonin turnover was lowest in winter and climbed with the hours of bright sunlight (Lambert et al., 2002). Melatonin, made in darkness, is the other half of the loop: long winter nights stretch the melatonin signal, while bright morning light both shuts melatonin down and resets the clock.

All of this runs through non-visual photoreception, whose sensitivity is driven largely by melanopsin and is best read in melanopic units, the kind of figure an iPhone meter such as Wavelength puts to a room that feels plenty bright in December but may be well short of the dose. The consensus calls for at least 250 lux melanopic EDI at eye level during the day, dropping below 10 lux in the 3 hours before bed and near 1 lux during sleep (Brown et al., 2022).

What the research shows

SAD is common, and it tracks geography as predicted. A 2025 systematic review and meta-analysis of 24 studies (32,866 participants) put winter-pattern SAD at about 5.0 percent, with a further 9.4 percent subsyndromal, and tied higher latitude to higher prevalence (Kim et al., 2025). US figures run from roughly 1.4 percent in Florida to 9.7 percent in New Hampshire.

Timed bright light is the best-supported treatment. A meta-analysis of randomized trials found a large effect for bright light in SAD (effect size 0.84) and a comparable one for dawn simulation (Golden et al., 2005). Head to head in the CAN-SAD trial, 10,000-lux light for 30 minutes each morning matched fluoxetine 20 mg/day, about a 67 percent response in each arm (Lam et al., 2006).

When the light arrives matters as much as how bright it is. Early-morning light beat midday and evening light; response grew with the size of the clock’s phase advance, and the best window fell roughly 8.5 hours after melatonin onset, with no such relationship for evening light (Terman et al., 2001).

Frequently asked questions

References

Related guides

Wavelength is a wellness and education tool, not a medical device. This page summarizes published research and is not medical advice. Consult a qualified clinician about any health condition or before starting light therapy.